|
1. |
Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 691-699
James R. Sowers,
Preview
|
|
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
2. |
Contrasting Autonomic and Hemodynamic Effects of Insulin in Healthy Elderly Versus Young Subjects |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 700-705
Martin Hausberg,
Robert P. Hoffman,
Virend K. Somers,
Christine A. Sinkey,
Allyn L. Mark,
Erling A. Anderson,
Preview
|
|
摘要:
Acute increases in plasma insulin produce both sympathoexcitation and vasodilation in normal young adults. Aging is associated with insulin resistance and may alter the sympathetic or the vascular responses to insulin. Therefore, we assessed sympathetic and vascular responses to acute physiological increases in plasma insulin levels in 10 healthy, normotensive elderly (65 +/- 2 years) and 12 normal young (27 +/- 1 years) subjects matched for body mass index (25 +/- 1 kg/m (2) in both groups). We measured muscle sympathetic nerve activity (microneurography), FBF (plethysmography), heart rate, and blood pressure and calculated forearm vascular resistance and insulin sensitivity (M value) during a 90-minute hyperinsulinemic/euglycemic clamp. M values were 4.3 +/- 0.4 mg [center dot] kg-1[center dot] min-1in the elderly and 8.4 +/- 1.4 mg [center dot] kg-1[center dot] min-1in the young subjects (P < .05). Baseline muscle sympathetic nerve activity was higher in the elderly subjects (33 +/- 3 versus 15 +/- 2 bursts per minute, P <.05); however, the absolute and percent increases in muscle sympathetic nerve activity were smaller in the elderly than in the young subjects (+10 +/- 1 versus +15 +/- 1 bursts per minute, or +37 +/- 11% versus +110 +/- 16%, P < .05). Forearm vascular resistance decreased with insulin from 46 +/- 2 to 31 +/- 3 units in the young but increased with insulin in the elderly subjects from 37 +/- 3 to 47 +/- 7 units (P < .05). Heart rate increased in young but not in elderly subjects. Insulin did not change blood pressure in either group. In conclusion, as opposed to vasodilation in young adults, insulin caused vasoconstriction in healthy elderly individuals. The failure of the vasodilator action of insulin in the elderly may permit even modest insulin-induced sympathoexcitation to elicit vasoconstriction. We speculate that the vasoconstrictor response to insulin may further potentiate insulin resistance in the elderly. (Hypertension. 1997;29:700-705.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
3. |
Effect of African-American Race and Hypertensive Left Ventricular Hypertrophy on Coronary Vascular Reactivity and Endothelial Function |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 706-714
Jan L. Houghton,
Vivienne E. Smith,
David S. Strogatz,
Nancy L. Henches,
Warren M. Breisblatt,
Albert A. Carr,
Preview
|
|
摘要:
Excess cardiovascular morbidity and mortality among African (black) Americans remains an important yet unexplained public health problem. One possible explanation proposes that intrinsic or acquired abnormalities in coronary vascular reactivity and endothelial function result in excess ischemia among black Americans. To examine this hypothesis, we subjected 80 individuals with normal coronary arteries to invasive testing of coronary artery and microvascular relaxation using intracoronary infusions of acetylcholine and adenosine, a Doppler tipped intracoronary guide wire, and quantitative coronary angiography. We measured the percent increase in coronary blood flow and epicardial diameter after graded infusion of intracoronary acetylcholine and in coronary blood flow after intracoronary adenosine in 31 normotensive subjects (10 black, 21 white) and 49 hypertensive subjects with left ventricular hypertrophy (25 black, 24 white). Categorical and multivariate analyses revealed that in response to intracoronary adenosine and acetylcholine, the depression in endothelium-independent and -dependent microvascular relaxation during peak agonist effect was largely related to the presence of chronic hypertension and left ventricular hypertrophy. Normotensive subjects demonstrated no intrinsic racial differences in conduit and resistance vessel vasoreactivity. In response to maximal infusion of acetylcholine, epicardial coronary arteries constricted similarly in black and white subjects with hypertensive left ventricular hypertrophy and dilated similarly in normotensive black and white subjects. Thus, our study shows that in a cohort of black and white subjects referred for coronary arteriography because of chest pain, African American race is not associated with excess intrinsic or acquired depression in coronary vascular relaxation during the peak effect of the endothelium-dependent and -independent agonists acetylcholine and adenosine, after adjustment for the presence of left ventricular hypertrophy. (Hypertension. 1997;29:706-714.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
4. |
The Cardiac beta-Adrenoceptor-Mediated Signaling Pathway and Its Alterations in Hypertensive Heart Disease |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 715-722
Maurizio Castellano,
Michael Bohm,
Preview
|
|
摘要:
Hypertension-induced cardiac hypertrophy is a predictor of the development of cardiac failure. It is unknown which cellular markers contribute to the progression from compensated hypertrophy to failure. In heart failure, several signal transduction defects leading to adenylate cyclase desensitization have been demonstrated, such as beta-adrenoceptor downregulation, increase of inhibitory G protein expression, and uncoupling of beta-adrenergic receptors, presumably by an increase of receptor kinase activity. In hypertensive heart disease, most studies have been performed in rat models of hypertension. As in heart failure, heterologous adenylyl cyclase desensitization occurs. The mechanisms are often different between the heterogeneous models for acquired and genetic hypertension, but Giprotein alterations and beta-adrenoceptor downregulation have been observed frequently. The underlying mechanism for desensitization is most likely a sympathetic activation in established hypertension rather than genetic alterations of signal transduction proteins. The data available suggest that beta-adrenergic desensitization could represent a mechanism that contributes to the progression from hypertrophy to failure. The key question remains whether those hypertensive patients who develop heart failure are more prone to beta-adrenergic desensitization or whether early intervention to reduce sympathetic activity is more effective in preventing or delaying the transition from compensated hypertrophy to overt failure. (Hypertension. 1997;29:715-722.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
5. |
Left Ventricular Hypertrophy Precedes Other Target-Organ Damage in Primary Aldosteronism |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 723-727
Yuji Shigematsu,
Mareomi Hamada,
Hideki Okayama,
Yuji Hara,
Yutaka Hayashi,
Koji Kodama,
Katsuhiko Kohara,
Kunio Hiwada,
Preview
|
|
摘要:
To elucidate whether there is a difference in the progression of target-organ damage between primary aldosteronism and essential hypertension, we compared left ventricular hypertrophy and extracardiac target-organ damage in 23 patients with primary aldosteronism and 116 patients with essential hypertension. The severity of hypertensive retinopathy and the renal involvement in primary aldosteronism were subclinical and similar to those in essential hypertension without left ventricular hypertrophy but significantly milder than those in essential hypertension with left ventricular hypertrophy. There was a strongly significant correlation between the degree of left ventricular mass index and the severity of hypertensive retinopathy and renal involvement independent of office blood pressure in essential hypertension. In contrast, left ventricular hypertrophy markedly progressed despite the mild extracardiac target-organ damage in primary aldosteronism. Left ventricular end-diastolic dimension index in primary aldosteronism (3.16 +/- 0.50 cm/m2) was significantly larger than in essential hypertension without (2.87 +/- 0.23) and with (2.88 +/- 0.22) left ventricular hypertrophy. On the other hand, there was no difference in extracardiac target-organ damage between 13 primary aldosteronism patients with eccentric left ventricular hypertrophy and the 26 essential hypertensive patients with eccentric left ventricular hypertrophy. The results suggest that predominantly volume load, be it due to aldosteronism or other mechanisms, resulting in eccentric left ventricular hypertrophy is less likely to cause extracardiac target-organ damage than hemodynamic or nonhemodynamic mechanisms resulting in concentric left ventricular hypertrophy. (Hypertension. 1997;29:723-727.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
6. |
Characteristics of Diabetes, Blood Pressure, and Cardiac and Renal Complications in Otsuka Long-Evans Tokushima Fatty Rats |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 728-735
Keiko Yagi,
Shokei Kim,
Hideki Wanibuchi,
Tatsuya Yamashita,
Yoshitaka Yamamura,
Hiroshi Iwao,
Preview
|
|
摘要:
To characterize the molecular mechanism of cardiac and renal complications in non-insulin-dependent diabetes mellitus (NIDDM), we examined the gene expression of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a new animal model for human NIDDM, at the ages of 14 weeks (prediabetic stage), 30 weeks (NIDDM stage), and 54 weeks (IDDM stage). Tissue mRNA levels were measured by Northern blot analysis. In 14-week-old OLETF rats, cardiac mRNAs for transforming growth factor-beta1(TGF-beta1) and extracellular matrix, including collagen types I, III, and IV and laminin, were significantly increased compared with control rats (Long-Evans Tokushima Otsuka rats). Cardiac beta-myosin heavy chain (MHC) mRNA of OLETF was increased at 30 and 54 weeks of age, whereas alpha-MHC mRNA of OLETF was inversely decreased at 54 weeks. Marked perivascular fibrosis was seen in the hearts of OLETF rats from 30 weeks of age. In the kidney of OLETF rats, glomerular TGF-beta1expression was temporally increased at 30 weeks of age, followed by glomerulosclerosis characterized by mesangial proliferation, thickening of the basement membrane, and nodular lesions. Blood pressure of OLETF rats remained higher than that of control rats from the prediabetic stage to the IDDM stage. Thus, in OLETF rats, cardiac fibrosis-related gene expressions were already enhanced at the prediabetic stage, which supports the involvement of these gene expressions in cardiac perivascular fibrosis. The antithetical change in beta- and alpha-MHC expressions seems to participate in the decreased cardiac contractility seen in diabetes. Furthermore, TGF-beta1may also contribute to glomerulosclerosis of OLETF rats. OLETF rats seem to be a useful model to study the mechanism of hypertension and cardiac and renal complications in NIDDM. (Hypertension. 1997;29:728-735.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
7. |
Hypertension Causes Premature Aging of Endothelial Function in Humans |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 736-743
Stefano Taddei,
Agostino Virdis,
Paola Mattei,
Lorenzo Ghiadoni,
Ciro Basile Fasolo,
Isabella Sudano,
Antonio Salvetti,
Preview
|
|
摘要:
60 years), L-arginine was no longer effective, and indomethacin exerted a potentiating action that was positively related to advancing age. In normotensive and hypertensive humans, similar mechanisms, including dysfunction of the nitric oxide pathway and production of cyclooxygenase-dependent vasoconstrictors, cause age-related impairment of endothelium-dependent vasodilation, and only their earlier appearance characterizes hypertensive disease. Thus, the endothelial dysfunction that occurs in hypertension seems to represent an accelerated form of dysfunction that occurs in aging. (Hypertension. 1997;29:736-743.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
8. |
Effect of Calcium Channel or beta-Blockade on the Progression of Diabetic Nephropathy in African Americans |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 744-750
George L. Bakris,
Amy Mangrum,
J. Brian Copley,
Nancy Vicknair,
Rebecca Sadler,
Preview
|
|
摘要:
beta-Blockers are known to slow the progression of diabetic nephropathy by lowering arterial pressure. Moreover, in individuals with diabetic nephropathy, antihypertensive agents that provide sustained reductions in proteinuria slow the rate of decline in renal function compared with agents without this antiproteinuric effect. To examine whether differential effects on proteinuria affect the progression of diabetic nephropathy, we conducted a randomized study that compared the effects of a heart rate-lowering calcium channel blocker, sustained-release verapamil, with those of a beta-blocker, atenolol, on the progression of diabetic renal disease. The primary end point of the study was a change in creatinine clearance slope. Thirty-four African Americans with the following inclusion criteria were randomized to one of the two groups: serum creatinine greater than 1.4 mg/dL, proteinuria greater than 1500 mg/d, longer than a 5-year history of both non-insulin-dependent diabetes mellitus and hypertension, and exclusion of other renal diseases. Goal blood pressure was less than 140/90 mm Hg. All subjects received loop diuretics as second line agents to help achieve the blood pressure goal. Twenty-four-hour urinary protein and sodium excretions as well as creatinine clearance were measured at 6-month intervals. Blood pressure was measured every 3 months. After a mean follow-up of 54 +/- 6 months, the calcium channel blocker group demonstrated both a slower rate of decline in creatinine clearance (-1.7 +/- 0.9 versus -3.7 +/- 1.4 mL/min per year per 1.73 m2, P < .01) and a greater reduction in proteinuria compared with the atenolol group. Additionally, a greater proportion of the atenolol group had a 50% or more increase in serum creatinine compared with the verapamil group (32 +/- 9% versus 16 +/- 7%, P < .05). These between-group differences could not be explained by differences in blood pressure control. These data support the concept that antihypertensive agents that persistently maintain reductions in both arterial pressure and proteinuria slow the progression of diabetic renal disease in African Americans to a greater extent than those agents without these effects. (Hypertension. 1997;29:744-750.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
9. |
Calcium Channel Blockers Blunt Postural Cutaneous Vasoconstriction in Hypertensive Patients |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 751-756
Maria Letizia Iabichella,
Giulia Dell'Omo,
Elio Melillo,
Roberto Pedrinelli,
Preview
|
|
摘要:
The aim of this work was to test whether calcium channel blockers interfere with skin vasoconstrictor reflexes that minimize postural increases in capillary pressure and avoid fluid extravasation and eventually subcutaneous edema. Studies were conducted in 23 untreated mild to moderate essential hypertensives; drugs, either calcium channel blockers or not, were given for 2 weeks according to a crossover, sequence-randomized design. Skin blood flow was measured by laser Doppler flowmetry in two skin areas: (1) the dorsum of the foot, where arteriovenous anastomoses are poorly represented, and (2) the plantar surface of the great toe, where those anastomoses are predominant. Determinations were obtained both with the foot at heart level and with it placed passively 50 cm below the heart level; percent flow changes from the horizontal to the dependent position were the measure of postural vasoconstriction. Two dihydropyridine derivatives, amlodipine (10 mg UID) and nifedipine (60 mg UID), and verapamil (240 mg BID), a chemically unrelated compound, diminished to similar extents the postural fall in skin blood flow at the dorsum of the foot. Blockade of alpha1-adrenergic and AT-1 subtype angiotensin II receptors by doxazosin (4 mg UID) and losartan (50 mg UID), respectively, exerted no effect. Postural skin blood flow responses at the plantar surface of the great toe were unmodified during the pharmacological trials. Thus, calcium channel blockers of different chemical origins antagonized postural skin vasoconstriction at the dorsum of the foot. The data indicate altered postural capillary blood flow regulation, since arteriovenous anastomoses are anatomically absent at this site; the effect was independent of either alpha1-adrenoceptor or angiotensin II receptor antagonism. Interference with skin postural vasoconstrictor mechanisms may result in net filtration of fluid to the extravascular compartment. This mechanism might explain the as yet unknown pathogenesis of ankle edema during treatment with calcium antagonists. (Hypertension. 1997;29:751-756.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
10. |
Bradykinin B2Receptor Modulates Renal Prostaglandin E2and Nitric Oxide |
|
Hypertension,
Volume 29,
Issue 3,
1997,
Page 757-759
Helmy M. Siragy,
Ayad A. Jaffa,
Harry S. Margolius,
Preview
|
|
摘要:
Bradykinin and lys-bradykinin generated intrarenally appear to be important renal paracrine hormones. However, the renal effects of endogenously generated bradykinin are still not clearly defined. In this study, we measured acute changes in renal excretory and hemodynamic functions and renal cortical interstitial fluid levels of bradykinin, prostaglandin E2, and cGMP in response to an acute intrarenal arterial infusion of the bradykinin B2receptor antagonist Hoe 140 (icatibant), cyclooxygenase inhibitor indomethacin, or nitric oxide synthase inhibitor NG-monomethyl-L-arginine (L-NMMA) given individually or combined in uninephrectomized, conscious dogs (n = 10) in low sodium balance. Icatibant caused a significant decrease in urine flow, urinary sodium excretion, and renal plasma flow rate (each P < .001). Glomerular filtration rate did not change during icatibant administration. Icatibant produced an unexpected large increase in renal interstitial fluid bradykinin (P < .0001) while decreasing renal interstitial fluid prostaglandin E2and cGMP (each P < .001). Both indomethacin and L-NMMA when given individually caused significant antidiuresis and antinatriuresis and decreased renal blood flow (each P < .001). Glomerular filtration rate decreased during L-NMMA administration (P < .001) and did not change during indomethacin administration. Combined administration of icatibant and indomethacin or L-NMMA caused significant decreases in renal excretory and hemodynamic functions, which were not different from changes observed with icatibant alone. The failure of icatibant to change renal function after inhibition of cyclooxygenase and nitric oxide synthase activity suggests that the effects of kinin B2receptor are mediated by intrarenal prostaglandin E2and nitric oxide generation. The increase in renal interstitial fluid bradykinin during icatibant requires further study of possible alterations in kinin synthesis, degradation, or clearance as a result of B2receptor blockade. (Hypertension. 1997;29:757-762.)
ISSN:0194-911X
出版商:OVID
年代:1997
数据来源: OVID
|
|